Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 940-029-4
CAS number: 1474044-86-4
The acute toxicity of Neononanoic acid glycidyl ester was accessed by an O.E.C.D. test guideline 425 UDP study. The rat acute dermal toxicity of the structural analog 2,3-epoxypropyl neodecanoate was evaluated by an O.E.C.D. test guideline 402 study.
The acute oral toxicity of the test substance, Neononanoic
acid glycidyl ester was accessed by an O.E.C.D. test guideline 425 UDP
method. The rate acute oral LD50 of the test substance is > 2000
mg/kg of body weight under the conditions of the study.
The structural analog test substance, 2,3-epoxypropyl
neodecanoate was accessed for acute dermal toxicity to the rat by an
O.E.C.D. test guideline 402 study. The test substance had an acute rat
dermal LD50 of > 2000 mg/kg/day with little evidence of dermal
irritation at the test sites. It is anticipated that Neononanoic
acid glycidyl ester will behave in a similar manner.
Based on acute oral and dermal LD50 values of > 2000 mg/kg of body
weight, Classification and Labeling is not required for these endpoints.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Esta web utiliza cookies para mejorar su experiencia de navegación en nuestros sitios web.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again